• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Epigenetic and Immune Regulation of Colorectal Cancer Stem Cells.结直肠癌干细胞的表观遗传与免疫调节
Curr Colorectal Cancer Rep. 2015 Dec;11(6):414-421. doi: 10.1007/s11888-015-0301-6. Epub 2015 Oct 10.
2
Heterogeneity of Colon Cancer Stem Cells.结直肠癌干细胞的异质性。
Adv Exp Med Biol. 2019;1139:115-126. doi: 10.1007/978-3-030-14366-4_7.
3
Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs.结直肠癌干细胞与免疫细胞在肿瘤发生中的相互作用以及靶向结直肠癌干细胞的策略。
Exp Hematol Oncol. 2024 Jan 22;13(1):6. doi: 10.1186/s40164-024-00474-x.
4
Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.不断发展的癌症干细胞治疗靶点策略。
Adv Cancer Res. 2016;131:159-91. doi: 10.1016/bs.acr.2016.04.003. Epub 2016 Jun 3.
5
Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.基于癌症干细胞的治疗方法的新兴功能标志物:了解用于靶向转移的信号网络。
Semin Cancer Biol. 2018 Dec;53:90-109. doi: 10.1016/j.semcancer.2018.06.006. Epub 2018 Jun 30.
6
Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.结直肠癌干细胞通过上调含F-Box/WD重复序列蛋白7并随后降解c-Myc获得化疗耐药性。
Stem Cells. 2017 Sep;35(9):2027-2036. doi: 10.1002/stem.2668. Epub 2017 Jul 31.
7
Cancer Stem Cells: Emerging Key Players in Immune Evasion of Cancers.癌症干细胞:癌症免疫逃逸中新兴的关键角色。
Front Cell Dev Biol. 2021 Jun 21;9:692940. doi: 10.3389/fcell.2021.692940. eCollection 2021.
8
Cancer Stem Cell-Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy Resistance.基于癌症干细胞的结直肠癌模型揭示了治疗抗性的分子决定因素。
Stem Cells Transl Med. 2016 Apr;5(4):511-23. doi: 10.5966/sctm.2015-0214. Epub 2016 Mar 8.
9
Heterogeneity in Colorectal Cancer Stem Cells.结直肠癌干细胞的异质性。
Cancer Prev Res (Phila). 2019 Jul;12(7):413-420. doi: 10.1158/1940-6207.CAPR-18-0482. Epub 2019 May 17.
10
Histone modifications: Targeting head and neck cancer stem cells.组蛋白修饰:针对头颈部癌症干细胞。
World J Stem Cells. 2014 Nov 26;6(5):511-25. doi: 10.4252/wjsc.v6.i5.511.

引用本文的文献

1
The Role of GREMLIN1, a Bone Morphogenetic Protein Antagonist, in Cancer Stem Cell Regulation.骨形态发生蛋白拮抗剂GREMLIN1在癌症干细胞调控中的作用
Cells. 2025 Apr 11;14(8):578. doi: 10.3390/cells14080578.
2
Notch receptor/ligand diversity: contribution to colorectal cancer stem cell heterogeneity.Notch受体/配体的多样性:对结直肠癌干细胞异质性的影响
Front Cell Dev Biol. 2023 Oct 4;11:1231416. doi: 10.3389/fcell.2023.1231416. eCollection 2023.
3
Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.肿瘤微环境中癌症干细胞治疗靶点的研究进展:最新综述
Cells. 2020 Aug 13;9(8):1896. doi: 10.3390/cells9081896.
4
IL-6 mediates platinum-induced enrichment of ovarian cancer stem cells.IL-6 介导铂诱导的卵巢癌细胞干性富集。
JCI Insight. 2018 Dec 6;3(23):122360. doi: 10.1172/jci.insight.122360.
5
Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy.Fas 表达和功能的丧失与结肠癌对免疫检查点抑制剂免疫治疗的耐药性相关。
Mol Cancer Res. 2019 Feb;17(2):420-430. doi: 10.1158/1541-7786.MCR-18-0455. Epub 2018 Nov 14.

本文引用的文献

1
Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.前列腺素 E2 促进小鼠结直肠癌干细胞的扩增和转移。
Gastroenterology. 2015 Dec;149(7):1884-1895.e4. doi: 10.1053/j.gastro.2015.07.064. Epub 2015 Aug 7.
2
Identification of Global DNA Methylation Signatures in Glioblastoma-Derived Cancer Stem Cells.胶质母细胞瘤来源的癌症干细胞中全基因组DNA甲基化特征的鉴定
J Genet Genomics. 2015 Jul 20;42(7):355-71. doi: 10.1016/j.jgg.2015.06.003. Epub 2015 Jun 24.
3
H3K9 Trimethylation Silences Fas Expression To Confer Colon Carcinoma Immune Escape and 5-Fluorouracil Chemoresistance.H3K9三甲基化使Fas表达沉默,从而导致结肠癌免疫逃逸和5-氟尿嘧啶化疗耐药。
J Immunol. 2015 Aug 15;195(4):1868-82. doi: 10.4049/jimmunol.1402243. Epub 2015 Jul 1.
4
Krt19(+)/Lgr5(-) Cells Are Radioresistant Cancer-Initiating Stem Cells in the Colon and Intestine.Krt19(+) / Lgr5(-) 细胞是结肠和肠道中具有放射抗性的癌症起始干细胞。
Cell Stem Cell. 2015 Jun 4;16(6):627-38. doi: 10.1016/j.stem.2015.04.013.
5
The histone methyltransferase EZH2 promotes mammary stem and luminal progenitor cell expansion, metastasis and inhibits estrogen receptor-positive cellular differentiation in a model of basal breast cancer.在基底样乳腺癌模型中,组蛋白甲基转移酶EZH2可促进乳腺干细胞和管腔祖细胞的扩增、转移,并抑制雌激素受体阳性细胞的分化。
Oncol Rep. 2015 Jul;34(1):455-60. doi: 10.3892/or.2015.4003. Epub 2015 May 21.
6
Microenvironmental control of stem cell fate in intestinal homeostasis and disease.肠道稳态与疾病中干细胞命运的微环境调控
J Pathol. 2015 Oct;237(2):135-45. doi: 10.1002/path.4563. Epub 2015 Jun 15.
7
DNMT1 is essential for mammary and cancer stem cell maintenance and tumorigenesis.DNA甲基转移酶1(DNMT1)对于乳腺和癌症干细胞的维持以及肿瘤发生至关重要。
Nat Commun. 2015 Apr 24;6:6910. doi: 10.1038/ncomms7910.
8
The CDX1-microRNA-215 axis regulates colorectal cancer stem cell differentiation.CDX1-微小RNA-215轴调控结直肠癌干细胞分化。
Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):E1550-8. doi: 10.1073/pnas.1503370112. Epub 2015 Mar 16.
9
IFNγ Induces DNA Methylation-Silenced GPR109A Expression via pSTAT1/p300 and H3K18 Acetylation in Colon Cancer.IFNγ 通过 pSTAT1/p300 和 H3K18 乙酰化诱导结肠癌中 DNA 甲基化沉默的 GPR109A 表达。
Cancer Immunol Res. 2015 Jul;3(7):795-805. doi: 10.1158/2326-6066.CIR-14-0164. Epub 2015 Mar 3.
10
HDAC1 and HDAC2 collectively regulate intestinal stem cell homeostasis.组蛋白去乙酰化酶1(HDAC1)和组蛋白去乙酰化酶2(HDAC2)共同调节肠道干细胞的稳态。
FASEB J. 2015 May;29(5):2070-80. doi: 10.1096/fj.14-257931. Epub 2015 Feb 3.

结直肠癌干细胞的表观遗传与免疫调节

Epigenetic and Immune Regulation of Colorectal Cancer Stem Cells.

作者信息

Paschall Amy V, Liu Kebin

机构信息

Department of Biochemistry and Molecular Biology, Medical College of Georgia, Georgia Regents University, Augusta, GA 30912, USA. Cancer Center, Georgia Regents University, Augusta, GA 30912. Charlie Norwood VA Medical Center, Augusta, GA 30904, USA.

出版信息

Curr Colorectal Cancer Rep. 2015 Dec;11(6):414-421. doi: 10.1007/s11888-015-0301-6. Epub 2015 Oct 10.

DOI:10.1007/s11888-015-0301-6
PMID:30655730
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6333468/
Abstract

Colorectal cancer stem cells (CSCs) were initially considered to be a subset of undifferentiated tumor cells with well-defined phenotypic and molecular markers. However, emerging evidence indicates instead that colorectal CSCs are heterogeneous subsets of tumor cells that are continuously reshaped by the dynamic interactions between genetic, epigenetic, and immune factors in the tumor microenvironment. Thus, the colorectal CSC phenotypes and responsiveness to therapy may not only be a tumor cell-intrinsic feature, but also depend on tumor-extrinsic microenvironmental factors. Furthermore, emerging evidence also implicates colorectal CSCs in potential immune evasion. Therefore, understanding how colorectal CSC-intrinsic mechanisms cooperate with the extrinsic microenvironmental factors to dynamically shape colorectal CSC resistance to chemotherapy and immunotherapy holds great promise for development of targeted CSC therapies of advanced human CRC.

摘要

结直肠癌干细胞(CSCs)最初被认为是具有明确表型和分子标志物的未分化肿瘤细胞亚群。然而,新出现的证据表明,结直肠癌干细胞是肿瘤细胞的异质性亚群,它们在肿瘤微环境中通过遗传、表观遗传和免疫因素之间的动态相互作用而不断重塑。因此,结直肠癌干细胞的表型和对治疗的反应性可能不仅是肿瘤细胞内在的特征,还取决于肿瘤外在的微环境因素。此外,新出现的证据还表明结直肠癌干细胞存在潜在的免疫逃逸。因此,了解结直肠癌干细胞内在机制如何与外在微环境因素协同作用,以动态塑造结直肠癌干细胞对化疗和免疫治疗的抗性,对于开发晚期人类结直肠癌的靶向干细胞疗法具有巨大的前景。